Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Biochimica Et Biophysica Acta|May 10, 2001
Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP)S A Hinke, S Manhart, N Pamir, et al.
International Journal of Obesity|July 1, 1991
Comparison of the enteroinsular axis in two strains of obese rat, the fatty Zucker and the JCR:LA-corpulentR A Pederson, R V Campos, A M Buchan, et al.
Canadian Journal of Physiology and Pharmacology|August 1, 1991
Insulin secretion and islet endocrine cell content at onset and during the early stages of diabetes in the BB rat: effect of the level of glycemic controlR A Pederson, S B Curtis, C B Chisholm, et al.
Regulatory Peptides|February 1, 1989
Gastrin release in obese Zucker ratsR A Pederson, R V Campos, C B Chan, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|October 30, 2001
Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake in elderly patients with diabetesG S Meneilly, C H McIntosh, R A Pederson, et al.
The Journal of Endocrinology|May 16, 2000
Role of glucose in chronic desensitization of isolated rat islets and mouse insulinoma (betaTC-3) cells to glucose-dependent insulinotropic polypeptideS A Hinke, R P Pauly, J Ehses, et al.
Biochimica Et Biophysica Acta|August 14, 1996
Isolation of a murine glucose-dependent insulinotropic polypeptide (GIP) cDNA from a tumor cell line (STC6-14) and quantification of glucose-induced increases in GIP mRNAP J Schieldrop, R W Gelling, R Elliot, et al.
Regulatory Peptides|April 30, 1997
GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitroR W Gelling, D H Coy, R A Pederson, et al.
Peptides|November 1, 1990
Expression of recombinant human glucose-dependent insulinotropic polypeptide in Escherichia coli by sequence-specific proteolysis of a protein A fusion proteinB K Chow, G W Morrow, M Ho, et al.
Canadian Journal of Physiology and Pharmacology|January 1, 1996
The insulinotropic region of gastric inhibitory polypeptide; fragment analysis suggests the bioactive site lies between residues 19 and 30G W Morrow, T J Kieffer, C H McIntosh, et al.
Pageof 9